EFG Asset Management (Americas)’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,924
Closed -$136K 136
2022
Q4
$136K Buy
11,924
+760
+7% +$11.3K 0.03% 130
2022
Q3
$190K Buy
+11,164
New +$240K 0.05% 130
2022
Q2
Sell
-7,994
Closed -$296K 129
2022
Q1
$296K Buy
7,994
+2,375
+42% +$92.6K 0.05% 124
2021
Q4
$256K Buy
5,619
+1,415
+34% +$73.9K 0.04% 129
2021
Q3
$266K Buy
+4,204
New +$320K 0.05% 134

Other funds holding CDNA

EFG Asset Management (Americas)'s CDNA Position: Q1 2023 in Review

EFG Asset Management (Americas) sold out of CareDx (CDNA) in Q1 2023, closing a stake of 11,924 shares — an estimated $136K sold.

EFG Asset Management (Americas) first reported a position in CDNA in Q3 2021 and held it in 5 quarters. The position peaked at $296K in Q1 2022. 156 funds tracked by Wall St. Rank hold CDNA as of Q1 2023.

  • EFG Asset Management (Americas) reported no remaining CareDx position as of Q1 2023 after selling out during the quarter.
  • EFG Asset Management (Americas) sold 11,924 CareDx shares in Q1 2023, an estimated $136K.
  • EFG Asset Management (Americas) first reported a position in CareDx in Q3 2021 and held it in 5 quarters.
  • EFG Asset Management (Americas)'s CareDx position peaked at $296K in Q1 2022.
  • 156 funds tracked by Wall St. Rank held CareDx as of Q1 2023.

Based on EFG Asset Management (Americas)'s 13F filing for Q1 2023, filed 4 May 2023.